IM Cannabis (IMCC) Depreciation & Amortization (CF) (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Depreciation & Amortization (CF) of $26980.6 for Q1 2026, down 15.84% year-over-year from $32058.2 in Q1 2025, and down 64.5% quarter-over-quarter from $76011.1 in Q4 2025.
IM Cannabis (IMCC) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
IM Cannabis' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $26980.6 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 15.84% year-over-year to $26980.6; the TTM figure through Mar 2026 stood at $223209.5 (up 23.24% YoY), while the FY2025 annual figure was $228033.4, down 11.05% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $26980.6, down from $76011.1 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $819475.5 in Q1 2022, with the low at $13601.1 in Q4 2024.
- The 5-year median for Depreciation & Amortization (CF) is $77703.7 (2024), against an average of $194641.5.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) plunged 84.29% in 2023, then soared 458.86% in 2025.
- IM Cannabis' Depreciation & Amortization (CF) stood at $378665.3 in 2022, then tumbled by 80.6% to $73453.6 in 2023, then sank by 81.48% to $13601.1 in 2024, then jumped by 458.86% to $76011.1 in 2025, then plunged by 64.5% to $26980.6 in 2026.
- Business Quant data shows IMCC's Depreciation & Amortization (CF) at $26980.6 in Q1 2026, $76011.1 in Q4 2025, and $61037.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 98,317.84 |
| Jun 30, 2026 | 98,317.84 |
| Mar 31, 2026 | 26,980.61 |
| Mar 31, 2026 | 26,980.61 |
| Dec 31, 2025 | 76,011.15 |
| Dec 31, 2025 | 76,011.15 |
| Sep 30, 2025 | 61,037.34 |
| Sep 30, 2025 | 61,037.34 |
| Jun 30, 2025 | 59,180.42 |
| Jun 30, 2025 | 59,180.42 |
| Mar 31, 2025 | 32,058.16 |
| Mar 31, 2025 | 32,058.16 |
| Dec 31, 2024 | 13,601.13 |
| Dec 31, 2024 | 13,601.13 |
| Sep 30, 2024 | 77,703.66 |
| Sep 30, 2024 | 77,703.66 |
| Jun 30, 2024 | 57,760.10 |
| Jun 30, 2024 | 57,760.10 |
| Mar 31, 2024 | 109,090.64 |
| Mar 31, 2024 | 109,090.64 |